The second patient had duodenal carcinoma with pancreatic invasion, in which BRAF V600E was found to be a driver gene mutation in the WES and was immunohistochemically confirmed to have MLH1 and PMS2 deletions. The gene discussed is BRAF; the disease is carcinoma of duodenum.